As of August 2026, according to Mettler-Toledo International's current financial statements, the company's 12-month EPS is $44.47. Mettler-Toledo International's EPS for 2025 amounted to $42.17, marking an increase from $40.67 in 2024. Mettler-Toledo International's earnings per share for the quarterly report ending on Jun 30, 2026 reached $11.57.
The annual EPS for the year 2025 was $42.17, an increase of 3.7% from $40.67 in 2024. The quarterly per-share earnings for the period ending Jun 30, 2026, was $11.57, indicating a 18.3% increase from the same quarter last year. MTD's 12-month EPS stands at $44.47 as of June 2026. Mettler-Toledo International's annual EPS in 2024 stood at $40.67, a 12.7% increase year-over-year.
During the last 12 months, Mettler-Toledo International has seen an EPS growth of 18.3% (YoY, quarterly). Throughout the last three years, the company had an average EPS growth of 2.8% per year. During the last 5 years, the company had an average EPS growth rate of 10.8%. When measured over a ten-year period, MTD's average EPS growth rate was 12.7%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| XYL Xylem Inc | 28.17 | 7.1% | 25.9% | 22.8% |
| TMO Thermo Fisher Scientific Inc | 30.82 | 7.2% | 0% | 2% |
| MTD Mettler-Toledo International Inc | 32.13 | 3.7% | 2.8% | 10.8% |
| DHR Danaher Corp | 34.78 | -4.9% | -19.7% | 0.4% |
| WAT Waters Corp | 47.5 | 0.5% | -2.9% | 5.2% |
| BIO Bio-Rad Laboratories Inc - Class A | 56.81 | 142.6% | N/A | -26.3% |
| BRKR Bruker Corp | N/A | -119.7% | N/A | N/A |
| HBIO Harvard Bioscience Inc | N/A | -357.1% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.